Table 4:
Association
of MnSOD Ala16Val polymorphism with diabetic
complications Chi-square test was used to determine significance at p <
0.05.
|
|
No
complications (n
= 32) |
With
complications (n
= 27) |
p-Value |
OR
(95% CI) |
|
|
Genotype |
|
|
|
|
|
|
CC (Ala) (n = 6) |
5/6 (83.3%) |
1/6 (16.7%) |
0.021 |
4.364 (1.440-13.336)* |
|
|
CT (Ala/Val) (n
= 29) |
19/29 (65.5%) |
10/29 (34.5%) |
|||
|
TT (Val) (n = 24) |
8/24 (33.3%) |
16/24 (66.7%) |
|||
|
Allele |
|
|
|
|
|
|
f(C) |
45.4% |
22% |
|
|
|
|
f(T) |
54.6% |
78% |
|
|
|
*Risk was calculated for a Val homozygote
carrier